002390.SZ
信邦制药
SZSE · Healthcare · F 批发零售 · CN
CNY 3.00
−1.32%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.4B | 5.6B | 6.0B | 6.5B | 6.4B |
| Cost of Revenue | 4.5B | 4.6B | 5.0B | 5.2B | 5.1B |
| Gross Profit | 964.6M | 991.7M | 1.0B | 1.2B | 1.2B |
| Operating Expenses | |||||
| R&D Expense | 7.0M | 5.8M | 4.6M | 4.7M | 1.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 352.3M | 356.0M | 364.2M | 394.4M | 420.8M |
| Selling & Marketing Expense | 221.3M | 253.7M | 305.7M | 343.4M | 393.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 630.8M | 667.6M | 716.1M | 797.7M | 882.5M |
| Cost and Expenses | 5.1B | 5.3B | 5.7B | 6.0B | 6.0B |
| Operating Income (EBIT) | 251.3M | 237.3M | 254.8M | 385.0M | 316.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 245.1M | 230.0M | 185.5M | 396.0M | 313.4M |
| Income Tax Expense | 42.6M | 38.2M | 29.8M | 42.2M | 45.1M |
| Bottom Line | |||||
| Net Income | 127.7M | 120.3M | 101.4M | 287.2M | 224.4M |
| Earnings from Cont. Ops | 202.5M | 191.8M | 155.7M | 353.8M | 268.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 127.7M | 120.3M | 101.4M | 287.2M | 224.4M |
| Per Share | |||||
| Basic EPS | CN¥0.07 | CN¥0.06 | CN¥0.05 | CN¥0.15 | CN¥0.12 |
| Diluted EPS | CN¥0.07 | CN¥0.06 | CN¥0.05 | CN¥0.15 | CN¥0.12 |
| Revenue Per Share | CN¥2.87 | CN¥2.96 | CN¥3.17 | CN¥3.37 | CN¥3.40 |
| Shares | |||||
| Basic Shares Outstanding | 1.9B | 1.9B | 1.9B | 1.9B | 1.9B |
| Diluted Shares Outstanding | 1.9B | 1.9B | 1.9B | 1.9B | 1.9B |
| Profitability Metrics | |||||
| EBITDA | — | 448.9M | 484.0M | 632.8M | 577.4M |
| D&A | — | 211.6M | 229.1M | 247.8M | 261.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026